Sequence Bio
YC S19St. John's, CA · Founded 2013 · 52 employees · 3 known investors
Sequence Bio discovers genetic causes of disease within Newfoundland and Labrador's founder population to develop breakthrough treatments, diagnostics, and preventions. The company focuses on translational biology and genetics research for patients globally.
AI & Machine LearningBiotechDeep TechHealthtechGenomicsTherapeuticsDrug discoveryCanadaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (S19)
Sequence Bio was founded in 2013 by Jeremy Grushcow and Chris Gardner.
JG
Jeremy Grushcowin𝕏Co-founder · Chief Business Officer2015–2019Jeremy Grushcow earned a Ph.D. in Molecular Genetics and Cell Biology and a J.D. with Honors from the University of Chicago. He served as Chief Business Officer at Sequence Bio and as Executive Vice President of Strategic Development at Antibe Therapeutics, where he managed corporate partnerships and clinical development programs.
CG
Chris GardnerinCo-founder · Strategic Advisor2022–2024
LH
Lynn HealeyChief Executive Officer
TB
Tom BarberChief Scientific Officer
Investors · 3
Founder mafia
2 people who came through Sequence Bio went on to found or lead other companies.
Competitors · 3
by search overlap
Sequencing4 shared keywordsSequencing.com offers free storage of personal DNA data along with tools and reports that turn genetic testing results into health-related insights for consumers. The company addresses data storage, usability, and privacy challenges created by widely available consumer genetic testing.
Gem4 shared keywordsGem is an AI recruiting platform that helps talent acquisition teams find candidates and hire faster. It serves recruiting teams at startups and enterprises.
IDbyDNA3 shared keywordsScalable, high throughput DNA sequencing platforms.
Companies competing with Sequence Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Sequence Bio do?
- Sequence Bio discovers genetic causes of disease within Newfoundland and Labrador's founder population to develop breakthrough treatments, diagnostics, and preventions. The company focuses on translational biology and genetics research for patients globally.
- Who founded Sequence Bio?
- Sequence Bio was founded by Jeremy Grushcow, Chris Gardner in 2013.
- Who are Sequence Bio's investors?
- Sequence Bio's investors include DCVC (Data Collective), Killick Capital, Y Combinator.
- Where is Sequence Bio headquartered?
- Sequence Bio is headquartered in St. John's, CA.